16th Joint EMA/EUnetHTA Meeting, 7 December 2018
On 7th December the European Medicines Agency hosted the 16th joint meeting with the European network for Health Technology Assessment (EUnetHTA). EMA and EUnetHTA have been holding regular dialogues since 2010 and they are an opportunity to progress the EMA/EUnetHTA work plan. Key discussion topics on this occasion were progressing different aspects of optimising evidence generation prospectively, development of guidelines and opportunities for enhanced collaboration, optimising the exchange at time of market entry, principles for the wording of the indication as well as joint analysis on the concepts of significant benefit and relative effectiveness.
A report from the meeting will be published later.